Search Login Register
Bromocriptine
(Parlodel)
Summary
Description:
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
Also Known As:
Parlodel; Bromocriptin; CB154; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptine Show All >>
Networked: 2879
relevant articles (301 outcomes,
334 trials/studies)
for this Drug
Key Diseases for which Bromocriptine is
Relevant
-
Prolactinoma (Prolactinomas)
:
38 outcomes 42 studies in 463 results
-
Hyperprolactinemia
:
38 outcomes 27 studies in 416 results
-
Parkinson Disease (Parkinson's Disease)
:
34 outcomes 63 studies in 287 results
-
Neoplasms (Cancer)
:
29 outcomes 11 studies in 292 results
-
Pituitary Neoplasms (Pituitary Adenoma)
:
14 outcomes 17 studies in 193 results
Show All >>
Drugs Related to Bromocriptine
-
Levodopa (L Dopa)
-
Prolactin
-
Dopamine Agonists (Dopamine Agonist)
-
Pergolide (Permax)
-
cabergoline
-
Bromocriptine (Parlodel)
-
Glucose (Dextrose)
-
ropinirole (Requip)
-
Octreotide (Sandostatin)
-
Clomiphene (Clomifene)
Show All >>
Therapies Related to Bromocriptine
-
Radiotherapy
-
Drug Therapy (Chemotherapy)
-
Aftercare (After-Treatment)
-
Pituitary Irradiation
-
Hypophysectomy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.